Drug
SD 101
SD 101: highest development phase Phase 1/2, developed by Dynavax Technologies. 4 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Dynavax Technologies
Trials
| Drug | Phase | Indication |
|---|---|---|
| SD-101 NCT02266147 | Phase 1/2 | B-cell Lymphoma |
| SD-101(1) NCT02521870 | Phase 1/2 | Metastatic Melanoma |
| SD-101 NCT00599001 | Phase 1 | |
| SD-101 NCT00823862 | Phase 1 | Chronic Hepatitis C |
Latest
No recent events.
Follow SD 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.